Literature DB >> 32767090

Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma.

Milena Pizzoferro1, Bartolomeo Cassano2, Claudio Altini3, Antonella Cacchione4, Maria Giuseppina Cefalo4, Vittorio Cannatà2, Maria Carmen Garganese3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32767090     DOI： 10.1007/s00259-020-04966-w

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Incidental Finding of Cerebellar Medulloblastoma on 68Ga-DOTATATE PET/CT in a Patient With Appendiceal Carcinoid.

Authors:  Mico Chan; Edward Hsiao
Journal:  Clin Nucl Med       Date:  2016-11       Impact factor: 7.794

Review 2.  Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning.

Authors:  Marta Cremonesi; Mahila Esmeralda Ferrari; Lisa Bodei; Carlo Chiesa; Anna Sarnelli; Cristina Garibaldi; Massimiliano Pacilio; Lidia Strigari; Paul Eugene Summers; Roberto Orecchia; Chiara Maria Grana; Francesca Botta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-21       Impact factor: 9.236

Review 3.  Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.

Authors:  Geetika Khanna; David Bushnell; M Sue O'Dorisio
Journal:  Oncologist       Date:  2008-04

4.  [Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma.

Authors:  Ganesan Vaidyanathan; Donna J Affleck; Xiao-Guang Zhao; Stephen T Keir; Michael R Zalutsky
Journal:  Curr Radiopharm       Date:  2010
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.